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The regulation of dendritic cells is far from fully
understood. Interestingly, several recent reports have
suggested a role for natural killer cells in affecting
dendritic cell maturation and function upon direct
contact between the cells. It is not known if this
interaction takes place also in vivo, or if a potential
interaction of natural killer cells and dendritic cells
would be affected by allergen exposure of the den-
dritic cells. The yeast Malassezia can act as an aller-
gen in atopic eczema/dermatitis syndrome, and
induce maturation of dendritic cells. Our aims were
to study the distribution of natural killer cells in the
skin from atopic eczema/dermatitis syndrome
patients with the emphasis on possible natural killer
cell±dendritic cell interaction, and to assess whether
the interaction of Malassezia with dendritic cells
would affect subsequent interaction between dendri-
tic cells and natural killer cells. A few scattered nat-
ural killer (CD56+/CD3±) cells were found in the
dermis of healthy individuals and in nonlesional skin
from atopic eczema/dermatitis syndrome patients.
In lesional skin and in biopsies from Malassezia
atopy-patch-test-positive skin, however, natural
killer cells were differentially distributed and for the
®rst time we could show close contact between nat-
ural killer cells and CD1a+ dendritic cells. Dendritic
cells preincubated with Malassezia became less sus-
ceptible to natural-killer-cell-induced cell death, sug-
gesting a direct effect imposed by Malassezia upon
interaction of dendritic cells with natural killer cells.
These ®ndings indicate that natural killer cells and
dendritic cells can interact in the skin and that
Malassezia affects the interaction between natural
killer cells and dendritic cells. Our data suggest that
natural killer cells may play a role in regulating den-
dritic cells in atopic eczema/dermatitis syndrome.
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T
he chronic in¯ammatory skin disease atopic dermatitis,
now referred to as atopic eczema/dermatitis syndrome
(AEDS) (Johansson et al, 2001), is increasing in
prevalence, and AEDS symptoms have been recorded
for as many as 20% of children throughout the world
(ISAAC, 1998; Leung, 2000). A complex interplay between
genetic predisposition, immune dysregulation, skin barrier dysfunc-
tion, lifestyle, and environmental factors is thought to be important
for the development of AEDS (Cooper, 1994; Werfel and Kapp,
1998; Alm et al, 1999). Evidence is accumulating that the
opportunistic yeast Malassezia, formerly known as Pityrosporum,
can contribute to the in¯ammatory reaction in AEDS
(Faergemann, 1999; Scheynius et al, 2002). The presence of IgE
speci®c to Malassezia has been reported in 32%±68% of AEDS
patients, and positive atopy patch test (APT) reactions in more than
half of the patients (Tengvall Linder et al, 2000; Scheynius et al,
2002). A correlation between positive APT and Th2-like response
in peripheral blood mononuclear cells has been described
(Johansson et al, 2002).
Dendritic cells (DCs) are recognized as the most potent of the
antigen-presenting cells due to their ability to activate naive T cells,
and they act as conductors of immune responses by functioning as a
link between the innate and acquired immune systems (Banchereau
et al, 2000; Granucci et al, 2001). Immature DCs can ef®ciently take
up antigens in the periphery and, following activation, differentiate
into professional antigen-presenting cells expressing CD83 and
high levels of costimulatory molecules. These mature DCs have
strongly reduced ability to take up antigen, but are instead excellent
at presenting antigen (Banchereau et al, 2000). Langerhans cells are
a subset of immature CD1a+ DCs found in the epidermis of the
skin. DCs with a Langerhans-cell-like phenotype can be generated
in vitro by culturing the CD14+ cell fraction of peripheral blood
mononuclear cells (Romani et al, 1994; Sallusto and Lanzavecchia,
1994) to gain monocyte-derived dendritic cells (MDDCs). As DCs
initiate adaptive immune responses, it is likely that they play an
important role in skewing the reaction to allergens towards a Th2-
like response in atopic individuals. We have shown previously that
interaction of Malassezia and human immature MDDCs leads to
uptake, maturation, and cytokine production, possibly promoting a
Th2-like immune response (Buentke et al, 2000; 2001).
The regulation of DCs by other cells is far from fully understood.
Natural killer (NK) cells are part of the innate immune system; their
ability to induce cell death in tumor cells and virus-infected cells
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has been studied intensely. More recently a potential role in
affecting DC regulation has been addressed. Several studies have
demonstrated an interaction between DCs and NK cells, indicating
an importance of cross-talk for their mutual regulation (Chambers
et al, 1996; Geldhof et al, 1998; Carbone et al, 1999; Fernandez et al,
1999; Wilson et al, 1999; Spaggiari et al, 2001; Ferlazzo et al, 2002;
Gerosa et al, 2002; Piccioli et al, 2002). It is not known if this
interaction takes place also in vivo, or if a potential interaction of
NK cells and DCs would be affected by allergen exposure of the
DCs. In this study, we addressed these questions by investigating
the presence of NK cells in the skin from AEDS patients and
healthy individuals. Speci®cally, we studied the effect of Malassezia
uptake by DCs on subsequent interactions with NK cells.
MATERIALS AND METHODS
Immunohistochemical and immuno¯uorescence staining of skin
biopsy specimens Skin specimens (4 mm punch biopsies) were taken
under local anesthesia from three healthy individuals, and from
nonlesional, lesional, and Malassezia extract APT-positive skin (at 24 h
and 72 h after provocation) from four AEDS patients who had serum
IgE antibodies speci®c for Malassezia (Tengvall Linder et al, 2000). The
biopsies were snap frozen on dry ice and stored at ±80°C until further
analysis. Acetone-®xed, 6 mm thick, cryostat sections were immuno-
histochemically stained with an anti-CD56 (MY31, Becton Dickinson,
Sweden) monoclonal antibody (MoAb), using Vectastain ABC-Elite
(Vector Laboratories, Burlingame, CA), according to the manufacturer's
protocol, and then developed with 3-amino-9-ethylcarbazole (0.02% wt/
vol, Aldrich-Chemie, Germany), followed by counterstaining with
Mayer's hematoxylin (Sigma, Sweden). CD56+ cells were identi®ed by
their de®nite brownish-red staining and visible nuclei. For double
immuno¯uorescence staining, the sections were incubated, ®rst, with
normal donkey or goat serum, followed by anti-CD56 MoAb overnight
at 4°C. Thereafter either donkey antimouse IgG Rhodamine Red-X
(Jackson Immunoresearch, GoÈteborgs Termometerfabrik, Sweden) or
goat antimouse IgG Alexa 546 (Molecular Probes, The Netherlands)
conjugated antibody was applied for 1.5 h at room temperature. Next,
normal mouse serum was added to the sections, followed by either a
¯uorescein isothiocyanate (FITC) conjugated anti-CD3 MoAb (SK4,
Becton Dickinson) or an FITC-conjugated anti-CD1a MoAb (NA1/34,
Dakopatts, Denmark) incubated overnight at 4°C. The sections were
evaluated using a Leica TCS SP2 confocal laser scanning microscope
system, equipped with an inverted Leica DM IRBE microscope, an
argon laser, and two HeNe lasers (Leica Microsystems, Germany). Oil
was used as immersion medium, and paraphenylenediamine in glycerol as
mounting medium to reduce fading (Johnson et al, 1982). Leica confocal
software was used to acquire and visualize the data. Staining was not
observed when irrelevant isotype-matched antibodies, mouse IgG1
(DAK-GO1, Dakopatts) or mouse IgG2a FITC (X39, Becton
Dickinson), were used or when primary antibodies were omitted.
Culturing of Malassezia M. sympodialis strain no. 42132,
previously designated M. furfur (Mayser & Gross, 2000; Scheynius et
al, 2002), was obtained from the American Type Culture Collection,
and is referred to here as Malassezia. The yeast was cultured at 37°C
for 4 d as previously described (Buentke et al, 2001), and then
harvested in sterile water and counted under a light microscope
before incubation with MDDCs. The endotoxin content was
determined in yeast culture supernatants from three independent
experiments, and was found to be less than 0.3 EU per ml (Limulus
test, performed by Apoteket, Stockholm, Sweden).
Generation of MDDCs from peripheral blood Buffy coats were
obtained from healthy donors from the Karolinska Hospital blood bank.
All the test samples were ImmunoCapTM, m70, negative to Malassezia
(= 0.35 kU per l) with a median total serum IgE level of 16 kU per l
(range 2.6±140 kU per l, reference ranges 1.6±122 kU per l), and
Phadiatop negative, i.e., did not show IgE reactivity to 11 common
airborne allergens (Pharmacia Diagnostics, Sweden). Monocytes were
isolated and MDDCs generated as previously described (Romani et al,
1994; Buentke et al, 2001). Brie¯y, the CD14+ cells were diluted to
4 3 105 cells per ml in complete culture medium, RPMIc [RPMI 1640
medium supplemented with 25 mg per ml gentamicin, 2 mM L-
glutamine, 100 IU per ml penicillin, 100 mg per ml streptomycin (Gibco
BRL, Life Technologies, U.K.), and 10% (vol/vol) fetal bovine serum
(FBS; Hyclone, Logan, UT), denoted ``RPMI 1640 with 10% FBS'',
supplemented with 50 mM 2-b-mercaptoethanol (Sigma), 550 U per ml
granulocyte±macrophage colony-stimulating factor (GM-CSF; Schering
Plough, Kenilworth, NJ), and 800 U per ml of recombinant human
interleukin-4 (rIL-4; Nordic BioSite, Sweden)], and cultured in 25 or
75 cm2 culture ¯asks (Costar, Cambridge, MA). To generate immature
MDDCs the CD14+ cells were cultured in a humidi®ed incubator with
6% CO2 in air for 6 d with refeeding on day 3. To mature the MDDCs,
RPMIc supplemented with cytokines (550 U per ml GM-CSF and
800 U per ml rIL-4) and 100 ng per ml of lipopolysaccharide (LPS)
(L8274, Escherichia coli serotype 026-B6, Sigma) was added to the cells on
day 6 of culture for an additional 46 h. The cells were harvested by
gentle resuspension. This study was approved by the local ethics
committee.
Interaction of MDDCs with Malassezia After 6 d of culture, the
MDDCs appeared as loosely adherent cell aggregates with typical
dendritic morphology. At this time point, the immature MDDCs were
harvested and cocultured with Malassezia, at a 1:5 ratio, in 25 cm2
culture ¯asks (Costar) at 37°C, in RPMIc supplemented with cytokines
(550 U per ml GM-CSF and 800 U per ml rIL-4) or in complete
culture medium alone, at a cell density of 4 3 105 MDDCs per ml, for
approximately 46 h. Malassezia was also incubated in RPMIc culture
medium alone for 46 h. Upon harvest, the cells were centrifuged, and
cell viability was assessed by trypan blue exclusion. Some MDDCs,
cocultured with or without Malassezia were air-dried onto three-well (®
internal 14 mm) microscope glass-slides (» 2 3 104 cells per well,
Novakemi, Sweden), and stored at ±80°C until use. In some
experiments, the culture supernatants were sterile ®ltered (0.2 mm) and
used to stimulate immature DCs or NK cells.
Characterization of the MDDCs At day 8 of culture, the MDDCs'
surface phenotype was assessed by ¯ow cytometry. The following FITC-
or phycoerythrin- (PE) conjugated mouse MoAbs were used: anti-CD1a
PE (T6-RD1, Coulter, Beckman-Coulter, Sweden), anti-CD14 FITC
(Leu-M3), anti-CD40 FITC (5C3), anti-CD54 PE (Leu-54), anti-CD80
FITC (L307.4), anti-CD83 FITC (HB15e), anti-CD86 FITC (2331
FUN-1), anti-HLA-DR FITC (L243), and anti-HLA-A, B, C FITC
(G46-2.6) from PharMingen/Becton Dickinson. Isotype-matched
antibodies, mouse IgG1 FITC- or PE-conjugated (X40), and mouse
IgG2a FITC-conjugated (X39) from Becton Dickinson were used as
negative controls. Approximately 5 3 104 cells were incubated for
30 min on ice with MoAbs. Gates were set according to a characteristic
forward-scatter pattern (Romani et al, 1996). The ¯ow cytometer was
calibrated according to the manufacturer's instructions before each
acquisition, and a minimum of 104 cells was acquired on a FACSCalibur
¯ow cytometer and analyzed using CellQuest software (Becton
Dickinson). A typical immature DC phenotype was present in the
MDDCs cultured only in medium (Table I) (Romani et al, 1994; 1996),
and the LPS-matured MDDCs showed a characteristic mature DC
phenotype (Table I) (Banchereau et al, 2000). Owing to auto-
¯uorescence of the yeast, ¯ow cytometry could not be used to assess the
phenotype of MDDCs cultured with Malassezia. Instead the expression
of CD83, the DC maturation marker (Zhou and Tedder, 1996), was
studied by immunocytochemistry. Frozen and acetone-®xed MDDCs
were stained with anti-CD83 (HB15e, PharMingen) MoAb, using
Vectastain ABC-Elite (Vector Laboratories, Burlingame, CA) according
to the manufacturer's protocol and as previously described (Buentke et al,
2001). The cells were evaluated with a Leiz microscope. A CD83+ cell
was de®ned as one with a de®nite brownish-red staining and a visible
nucleus. A minimum of 500 MDDCs were counted, and data were
compared using the nonparametric Wilcoxon matched pairs test. The
percentage of MDDCs cultured with Malassezia-expressing CD83 was
signi®cantly higher (p < 0.05) than for MDDCs cultured in medium,
i.e., 77% (median, range 46%±87%, n = 7) and 7.2% (1.4%±16%, n = 7),
respectively. The median purity of the MDDC cultures, as determined
by cell size and cell granularity using ¯ow cytometry, was 95% (median,
range 78%±98%, n = 12). The median viability of MDDCs incubated
with Malassezia for 46 h was 92% (range 84%±100%, n = 12), with LPS
93% (range 88%±97%, n = 5), and with medium only 96% (range 92%±
98%, n = 12), as determined by trypan blue exclusion.
Generation of short-term activated polyclonal NK cells Peripheral
blood mononuclear cells, depleted of CD14+ cells, were frozen in RPMI
1640 (Gibco BRL, Life Technologies) supplemented with 50% heat-
inactivated FBS and 10% dimethyl sulfoxide, and stored at ±150°C. To
generate autologous short-term activated polyclonal NK cells, peripheral
blood mononuclear cells were thawed and diluted to 2 3 106 cells per
ml in RPMI 1640 with 10% FBS supplemented with 1000 U per ml of
rIL-2 (Pepro Tech EC, U.K.), and then cultured in 25 cm2 culture ¯asks
at 37°C for 48 h. K562 cells, a human erythroleukemia line (a kind gift
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from Professor Giorgio Trinchieri, Schering-Plough Research Institute,
Laboratory for Immunological Research, Dardilly, France), were cultured
in RPMI 1640 with 10% FBS.
Time-lapse study MDDCs were seeded on glass coverslips in a 24-
well plate (Costar) at a cell density of 2 3 105 per ml in RPMIc
supplemented with GM-CSF and rIL-4 (550 U per ml GM-CSF and
800 U per ml rIL-4), and incubated at 37°C overnight to allow
adhesion. The coverslips were transferred to an inert aluminum chamber
containing RPMIc medium, and NK cells and Malassezia were added at
a 1:5 ratio before the chamber was sealed with silicon immediately
before the onset of the time-lapse photography as previously described
(Buentke et al, 2001).
NK-cell-mediated cytotoxicity The susceptibility of MDDCs to
autologous short-term activated polyclonal NK-cell-induced cell death
was measured in a standard 4 h 51Cr-release assay, at 37°C, using
Na2
51CrO4-labeled target cells in triplicate at various effector:target
ratios. 4 3 105 MDDCs and K562 cells were labeled with 40 ml
Na2
51CrO4 (Amersham, Sweden) for 1 h at 37°C, washed, and
resuspended in complete culture medium. The amount of speci®c 51Cr
released was expressed as a percentage and calculated as: % release =
[(experimental release ± spontaneous release)/(maximum release ±
spontaneous release)] 3 100. The spontaneous release was usually less
than 50% of the maximum. K562 cells, which do not express major
histocompatibility complex (MHC) class I molecules, were used as
control targets to assess the cytotoxic capacity of NK cells.
Effect of soluble factors from MDDC±Malassezia cocultures on the
interaction of NK cells and MDDCs In some experiments NK cells
and MDDCs were incubated in a 1:2 dilution of culture supernatant
from MDDCs, cultured with or without Malassezia, during the 4 h
51Cr-release assay. To assess the effect of soluble factors on the
phenotype of the MDDCs, 4 3 105 immature MDDCs per ml were
resuspended in RPMIc and incubated in 5 ml tubes (Falcon, Becton
Dickinson) for 4 h in a 1:2 dilution with sterile ®ltered supernatants
from MDDCs cultured either in medium or with Malassezia, and with
supernatants from Malassezia alone. The cells were harvested, labeled
with MoAbs for 30 min at 4°C, and analyzed by ¯ow cytometry. Data
were compared using the nonparametric Wilcoxon matched pairs test.
NK cells were also preincubated for 4 h at 37°C, in a 1:2 dilution of
sterile ®ltered culture supernatant from autologous MDDC cultures, with
or without Malassezia, and with supernatant from Malassezia cultured
alone. The NK cells were then incubated with Na2
51CrO4-labeled K562
cells, and their cytotoxic capacity was measured in the standard 4 h
51Cr-release assay.
RESULTS
NK cells are in close proximity to CD1a+ DCs in Malassezia
APT-positive skin from AEDS patients Immunohistochemical
staining revealed few scattered CD56+ cells in the dermis, close to
the epidermis, in skin biopsy specimens from healthy individuals
(Fig 1A) and in nonlesional skin from AEDS patients (Fig 1B). In
lesional and Malassezia APT-positive skin from the AEDS patients,
CD56+ cells were also found in the epidermis (Fig 1C) and
numerous CD56+ cells were observed in the dermal cell in®ltrates
(Fig 1D, E). To exclude the possibility that these CD56+ cells
could be NK T cells, double immuno¯uorescence staining with
anti-CD3 and anti-CD56 antibodies was performed. In healthy
skin, nonlesional, lesional, and Malassezia APT-positive skin at 24 h
and 72 h, all the CD56+ cells detected were CD3± and therefore
most likely NK cells (Fig 1F). We next asked the question whether
interaction between NK cells and DCs might take place in the skin
during the in¯ammatory disorder AEDS associated with Malassezia.
To address this question we performed double immuno-
¯uorescence staining using antibodies to CD56 and CD1a. In the
dermis, close to the epidermis, we were able to detect CD56+ NK
cells in close contact with CD1a+ DCs in Malassezia APT-positive
skin from AEDS patients (Fig 2).
NK-cell-mediated lysis of autologous MDDCs is lower after
preincubation with Malassezia By using time-lapse
photography, the interactions between NK cells and MDDCs in
the presence of Malassezia were followed for up to 6 h (Fig 3).
One consequence of the interaction between NK cells and DCs is
the NK-cell-mediated induction of cell death in DCs (Wilson et al,
1999). We observed that the interaction of several NK cells with an
MDDC resulted in death of the MDDC after approximately 2±3 h,
as apparent by the cell's rounding, swelling, loss of membrane
integrity, and release of small vesicles (Fig 3F±I). The MDDC's
dendrite comes into contact with NK cell no. 1 (Fig 3B) in a
manner like that shown in the skin, pictured in Fig 2. The effect of
Malassezia on the interaction between NK cells and DCs was
further studied using an in vitro assay for NK-cell-induced
cytotoxicity. MDDCs, preincubated with the yeast Malassezia for
46 h at a 1:5 ratio, were relatively less susceptible to NK-cell-
induced cell death compared to the control MDDCs incubated in
culture medium for the same time period (Fig 4). LPS-matured
MDDCs were less susceptible to NK-cell-induced cell death than
MDDCs incubated in medium and MDDCs cocultured with
Malassezia (Fig 4). A shorter coculture period (20 h) for MDDCs
and Malassezia did not result in reduced susceptibility to NK-cell-
mediated lysis (data not shown).
Soluble factors from cocultures of MDDCs and Malassezia
affect the cytotoxic capacity of NK cells The reduced
susceptibility of Malassezia-pretreated MDDCs to NK-cell-
mediated cytotoxicity might be a consequence of induction of a
more mature phenotype in the MDDCs, or an effect of soluble
Table I. Phenotype of the generated MDDCs
Phenotypic Immature MDDCs, Day 8 (n = 6-12)a LPS-matured MDDCb, Day 8 (n = 3-5)
Marker %c MFId %c MFId
CD1a 97 (88±100) 486 (104±847) 91 (85±98) 267 (56±332)
CD14 1.0 (0.0±4.8) 25 (17±179) 0.6 (0.2±0.9) 32 (17±42)
CD40 92 (82±96) 44 (26±83) 100 (94±100) 118 (39±136)
CD54 60 (12±94) 39 (24±64) 94 (92±96) 36 (24±75)
CD80 61 (36±95) 31 (12±59) 99 (88±100) 107 (35±198)
CD83 2.5 (0.3±7.6) 27 (13±40) 67 (57±83) 24 (14±36)
CD86 28 (13±59) 52 (21±89) 100 (99±100) 348 (130±440)
HLA-DR 100 (98±100) 349 (207±829) 100 (99±100) 614 (452±1644)
MHCI 100 (99±100) 197 (108±337) 100 (100±100) 763 (534±1022)
aNumber of experiments using cells from different healthy blood donors.
bMDDCs matured with LPS for 46 h.
cPositively stained MDDCs as analyzed by ¯ow cytometry. Results are given as median % (range). At least 104 cells per sample were analyzed.
dMean ¯uorescence intensity values presented as median (range).
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mediators produced by the MDDCs when activated with
Malassezia. To investigate whether soluble factors produced by
MDDCs preincubated with Malassezia affected NK-cell-induced
death in immature MDDCs, sterile ®ltered culture supernatant was
added during the 4 h 51Cr-release assay. This rendered the MDDCs
less susceptible to NK-cell-induced cell death (Fig 5).
Next we investigated whether the soluble factors produced by
MDDCs preincubated with Malassezia affected the phenotype of
the immature MDDCs. Using ¯ow cytometry, we found a
signi®cant increase of CD86+ MDDCs after addition of the
MDDC±Malassezia supernatant as well as after addition of MDDC±
LPS supernatant (data not shown). Heating of the supernatants to
56°C for 30 min, or addition of culture supernatants from yeast
alone, did not affect the CD86 expression (data not shown). No
differences were detected in the levels of CD1a, CD80, CD83,
HLA-DR, or MHC class I expression after addition of MDDC-
Malassezia supernatant (data not shown).
To further investigate the effect of soluble factors on the
cytotoxic capacity of NK cells, NK cells were preincubated with
culture supernatants. NK cells preincubated with MDDC±
Malassezia coculture supernatant killed K562 MHC class I negative
target cells to a lower degree than did NK cells incubated in
medium alone (Fig 6). Preincubation in supernatants from
Malassezia alone also resulted in less killing of the K562 cells,
indicating that factors derived directly from the yeast might affect
the activity of NK cells (Fig 6). Thus in addition to cell±cell
contact, soluble factors might also play a role in the interaction
between NK cells and DCs.
DISCUSSION
In this study we show that CD56+/CD3± NK cells are located close
to CD1a+ DCs in Malassezia APT-positive skin from AEDS
patients and that uptake of the allergenic yeast Malassezia by
immature MDDCs affects the subsequent interaction of MDDCs
and NK cells.
Despite increasing interest in NK cell±DC interactions, little
evidence indicates where this interaction takes place in vivo. It has
been shown, however, that cell±cell contact is important in the
cross-talk (Fernandez et al, 1999). Therefore we questioned
whether NK cells were present in the skin of patients with the
chronic in¯ammatory skin disease AEDS and, if so, might be
distributed in a way that they could interact with DCs. As described
here, we have demonstrated that NK cells and CD1a+ DCs can
appear in close contact in Malassezia APT-positive skin, suggesting
a role for NK cell±DC cross-talk. To our knowledge this is the ®rst
time that human NK cells and DCs have been shown to be in
actual contact in vivo. NK cells in human skin have been associated
with skin tumors, and occasional NK cells have been described in
lesional skin from patients with AEDS (Zachary et al, 1985;
Nakamura et al, 1995). The possible role of NK cells in AEDS has
been studied with somewhat contradictory results. The main focus
has been on the number of NK cells in peripheral blood and their
level of activation. In AEDS patients, both a numerical decrease of
NK cells and lowered NK cell activity compared to individuals
without AEDS has been reported (Wehrmann et al, 1990; Hashiro
and Okumura, 1998). Other groups found no difference in the
number of NK cells (Bouloc et al, 2000), or higher NK cell activity
than in healthy individuals (StrannegaÊrd and StrannegaÊrd, 1980).
Such con¯icting results may re¯ect the possibility that AEDS is a
heterogeneous disease (Johansson et al, 2001), or that treatments,
like topical steroid treatment, may have a systemic effect on NK
Figure 2. CD56+ NK cells and CD1a+ DCs in close contact in the
skin. Double immuno¯uorescence staining was performed with MoAbs
against CD56 and CD1a in skin biopsy specimens from AEDS patients
with Malassezia APT-positive reactions (72 h). The dendrites from the
CD1a+ DC can be seen in close proximity to the CD56+ NK cells. The
dotted line indicates the border between epidermis and dermis, with
dermis to the lower right in the picture. The specimen was analyzed
using confocal laser scanning microscopy (Leica Microsystems). Scale bar:
10 mm.
Figure 1. Different localization of NK cells in nonlesional
compared to lesional and Malassezia APT-positive skin from
AEDS patients. Using immunohistochemistry, CD56+ cells were found
in the dermis close to the epidermis in healthy individuals (A), and in
nonlesional skin from AEDS patients (B). In lesional (C, D) and
Malassezia APT-positive skin at 72 h (E) from AEDS patients, CD56+
cells were found in the epidermis (C) and dermal cell in®ltrates (D, E).
Epidermis is upwards in the pictures. Double immuno¯uorescence
staining, and confocal laser scanning microscopy, showed that the
CD56+ cells were CD3± (lesional skin, F).Scale bar: 10 mm.
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cells, thus in¯uencing experimental outcomes (Lesko et al, 1989).
Additionally, NK cells leaving the circulation could account for the
lower number reported in most studies. Support for this seems to
come from the numerous CD56+ cells we observed in dermal
in®ltrates in lesional and Malassezia APT-positive skin from AEDS
patients (Fig 1D, E) and the report of increased levels of the NK
cell chemoattractant MCP-1/CCL2 in patients with AEDS
(Kaburagi et al, 2001). CD1a+ cells in lesional skin of AEDS
patients can produced MDC/CCL22, another chemokine that
attracts NK cells, as well as DCs and Th2 cells (Vulcano et al, 2001).
We showed that NK cells were differentially distributed in
lesional and Malassezia APT-positive skin, with NK cells in the
epidermis and dermal in®ltrates, compared to nonlesional skin or
skin from healthy individuals. Besides, an inverse relation between
the NK cell activity and severity of eczema has been demonstrated
(Chiarelli et al, 1987). This, together with our ®ndings, points to a
role for NK cells in AEDS. Moreover, NK cells have been
implicated in the development of allergen-induced airway in¯am-
mation in a mouse model, further supporting the role of NK cells in
allergic diseases (Korsgren et al, 1999).
We then pursued our interest in studying the interaction of
human NK cells and DCs preincubated with an allergen. That the
opportunistic yeast Malassezia can act as an allergen and thereby
contribute to the in¯ammatory reaction in AEDS has been shown
in many studies (Faergemann, 1999; Scheynius et al, 2002), and we
have previously demonstrated that Malassesia can be taken up by
immature MDDCs, leading to their maturation and production of
cytokines with a potential to skew the immune reaction towards a
Th2-like response (Buentke et al, 2000; 2001). Using time-lapse
photography, we visualized the interaction between MDDCs and
several NK cells, in the presence of Malassezia. Similar events, like
swelling and loss of membrane integrity in the dying cell, were
recorded elsewhere by the same technique, although target cells
other than MDDCs were used (Eriksson et al, 1999). Spaggiari et al
showed the involvement of two activating receptors in the NK-
cell-mediated induction of cell death in DCs, and several recent
Figure 3. Time-lapse photography of short-term activated NK cells inducing cell death in an immature MDDC. Time-lapse photography
was used to study the NK-cell-mediated lysis of an immature MDDC. One picture was taken every third second. The nine different time points, after
coincubation of 2 3 105 immature MDDCs per ml with NK cells and Malassezia at a 1:5 ratio, are indicated in the upper right corner of each ®gure.
The numbers 1 and 2 are used to indicate the movement of two different NK cells. Contact between NK cell no. 1 and the MDDC is seen in (B) and
between NK cell no. 2 and the MDDC in (D), (E). Scale bar: 10 mm. The photographs are from one experiment representative of two.
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in vitro studies have demonstrated functional effects upon inter-
action between NK cells and DCs, implying an importance for
their mutual regulation (Spaggiari et al, 2001; Ferlazzo et al, 2002;
Gerosa et al, 2002; Piccioli et al, 2002).
Using a 51Cr-release assay, we found that immature MDDCs
cocultured with Malassezia for only 20 h were as susceptible to
NK-cell-induced cell death as MDDCs incubated in medium.
When immature MDDCs were cocultured with the yeast for 46 h,
however, they became less susceptible to NK-cell-induced cell
death, as were MDDCs matured with LPS. In one donor, an
autologous NK cell clone was also produced and the results
were the same as when using the short-term activated polyclonal
NK cells (data not shown). Additionally, Malassezia induced
maturation of MDDCs resulting in an increased number of
CD80-, CD83-, and CD86-positive cells after coculture for
approximately 46 h (Buentke et al, 2001). Evidently, MDDCs
pretreated with Malassezia require time to fully mature for the
reduced susceptibility to NK-cell-induced cell death to occur.
DCs in different maturation stages have been reported to be
differently susceptibility to NK cell lysis. Human immature DCs
were found to be more susceptible to autologous NK-cell-induced
cell death than DCs matured by LPS, tumor necrosis factor a,
monocyte-conditioned medium, or CD40L engagement (Carbone
et al, 1999; Wilson et al, 1999). Viral infection also rendered the
DCs less susceptible to NK-cell-induced cell death (Wilson et al,
1999), a conclusion that is in agreement with our observations. A
balance of activating and inhibiting signals determines whether NK
cells induce cell death in their target cells or not (Moretta et al,
2001). This indicates that maturation of DCs by microorganisms,
like yeast or virus, or products from microorganisms, like LPS,
in¯uence the surface phenotype of DCs or the factors they secrete
in such a way that the DCs become less susceptible to NK-cell-
mediated lysis.
In addition to cell±cell contact, our data show that soluble
factors may play a role in the NK cell±DC interaction.
Supernatant from cocultures of MDDCs and Malassezia ren-
dered untreated immature MDDCs less susceptible to NK-cell-
induced cell death, possibly through soluble factors with an
inhibitory effect on the NK cell. Cytokines produced by DCs,
such as IL-10 and IL-12, have been shown to modulate NK
cell activity (Goodier and Londei, 2000; Grufman and KaÈrre,
2000). We reported previously, however, that DC interaction
Figure 4. Immature MDDCs are less susceptible to autologous
NK-cell-induced cell death if preincubated with the yeast
Malassezia. The percentage lysis of K562 (circles), of MDDCs (4 3 103
per well) incubated in medium alone (squares), of MDDCs incubated for
46 h with the yeast Malassezia at a 1:5 ratio (®lled squares), and of
MDDCs cultured with LPS (100 ng per ml) for 46 h (triangles), by
autologous short-term activated polyclonal NK cells, was detected in a
4 h standard 51Cr-release assay. The results shown are from one of three
representative experiments, using cells from different blood donors.
Figure 5. Soluble factors in supernatants from cocultures of
MDDCs and Malassezia yeast cells lead to decreased induction of
autologous NK-cell-mediated cell death in immature MDDCs. A
4 h standard 51Cr-release assay was used to detect the percentage lysis by
NK cells of K562 (circles), of MDDCs (4 3 103 per well) cultured in
medium alone with no addition of culture supernatants (squares), of
MDDCs with addition of culture supernatant from autologous MDDCs
cultured in medium for 46 h (triangles), and of MDDCs with addition of
culture supernatant from autologous MDDCs cocultured with the yeast
Malassezia at a 1:5 ratio for 46 h (®lled triangles). The results shown are
from one of two representative experiments, using cells from different
blood donors.
Figure 6. The activity of autologous NK cells is inhibited by
soluble factors in supernatants from cocultures of MDDCs and
M. sympodialis. Short-term activated polyclonal NK cells were
preincubated with culture supernatant from MDDCs cultured with or
without Malassezia or from Malassezia alone, for 4 h, before the
cytotoxic capacity of the NK cells were assessed on the MHC class I
negative target cell line K562. Shown is the percentage lysis of K562 by
NK cells preincubated in medium (circles), of K562 by NK cells
preincubated in MDDC±Malassezia coculture supernatant (1:5 ratio for
46 h, ®lled triangles), and of K562 by NK cells preincubated in Malassezia
culture supernatant (46 h, triangles). These results are from one of four
representative experiments, using cells from different blood donors in a
4 h standard 51Cr-release assay. Using supernatants from MDDCs
incubated with medium resulted in a background induction of NK-cell-
mediated cell death of median 93% of the K562 cells at the 100:1 ratio
(range 91%±95%, n = 2).
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with Malassezia induced the production of IL-1b, tumor
necrosis factor a, and IL-18, but little or no IL-10 or IL-
12p70 (Buentke et al, 2001). Soluble factors in the coculture
supernatant did result in an increased number of CD86+
MDDCs, which might indicate that the soluble factors only
indirectly affected the NK cell±DC interaction. Upregulation of
MHC class I has been suggested to be of importance in the
interaction between mature DCs and NK cells (Ferlazzo et al,
2001), but we could not detect any increase in MHC class I
mean ¯uorescence intensity values for MDDCs stimulated with
coculture supernatant. Our results also indicate that factors from
Malassezia itself might have an inhibitory effect on the NK cell
cytotoxicity. Possibly the yeast cells produce some substance
similar to the reported viral IL-10 (Minter et al, 2001). In vitro
studies have shown that the ratio between NK cells and DCs is
important for the outcome of the cell interaction. At high ratios
NK-cell-induced cell death is the preferential outcome, whereas
mutual activation occurs at lower ratios (Piccioli et al, 2002;
own unpublished results). We have shown NK cell and DC
contact in Malassezia APT-positive skin, and that Malassezia
can in¯uence the interaction of NK cells and DCs in vitro,
leading to lower NK-cell-induced cell death. What the
preferential effect of Malassezia on the cross-talk in vivo is
needs to be further investigated. Our ®ndings that Malassesia
directly or indirectly affects the interaction of NK cells
and CD1a+ DCs, in concert with previous reports on the
involvement of Malassezia in AEDS (Faergemann, 1999;
Scheynius et al, 2002), suggest that the allergenic yeast may
interfere and/or affect the cross-talk between NK cells and DCs
in this disease.
In conclusion, our data indicate that CD56+ CD3± NK cells
and CD1a+ DCs can interact in allergen-provoked APT-positive
skin of AEDS patients. The differential distribution of NK cells
in nonlesional compared to lesional and Malassezia APT-positive
skin from AEDS patients suggests that NK cells may play a role
in regulating DCs in AEDS. These data also imply that the
allergenic yeast Malassezia affects the interaction of NK cells and
DCs, and that soluble factors from the DCs or the yeast may be of
importance in the NK cell±DC cross-talk in addition to cell±cell
contact.
We wish to thank Gunilla Jacobsson Ekman and Hojjatollah Eshaghi for valuable
technical support. This work was supported by grants from the Swedish Medical
Research Council (project no. 16x-7924), the Swedish Council for Work Life
Sciences, the Swedish Asthma and Allergy Association's Research Foundation, the
Swedish Foundation for Health Care Sciences and Allergy Research, the Queen
Silvia Jubilee Foundation, the Hesselman Foundation, and Karolinska Institutet.
REFERENCES
Alm JS, Swartz J, Lilja G, Scheynius A, Pershagen G: Atopy in children of families
with an anthroposophic lifestyle. Lancet 353:1485±1488, 1999
Banchereau J, Briere F, Caux C, et al: Immunobiology of dendritic cells. Annu Rev
Immunol 18:767±811, 2000
Bouloc A, Charue D, Nikolova M, Bensussan A: No modulation of circulating
natural killer cell and natural killer receptor bearing memory T cell subsets in
patients with atopic dermatitis. J Invest Dermatol 115:1160±1162, 2000
Buentke E, Zargari A, Hef¯er LC, Avila-Carino J, Savolainen J, Scheynius A: Uptake
of the yeast Malassezia furfur and its allergenic components by human immature
CD1a+ dendritic cells. Clin Exp Allergy 30:1759±1770, 2000
Buentke E, Hef¯er LC, Wallin RP, Lofman C, Ljunggren HG, Scheynius A: The
allergenic yeast Malassezia furfur induces maturation of human dendritic cells.
Clin Exp Allergy 31:1583±1593, 2001
Carbone E, Terrazzano G, Ruggiero G, et al: Recognition of autologous dendritic
cells by human NK cells. Eur J Immunol 29:4022±4029, 1999
Chambers BJ, Salcedo M, Ljunggren HG: Triggering of natural killer cells by the
costimulatory molecule CD80 (B7-1). Immunity 5:311±317, 1996
Chiarelli F, Canfora G, Verrotti A, Amerio P, Morgese G: Humoral and cellular
immunity in children with active and quiescent atopic dermatitis. Br J Dermatol
116:651±660, 1987
Cooper KD: Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest
Dermatol 102:128±137, 1994
Eriksson M, Leitz G, Fallman E, Axner O, Ryan JC, Nakamura MC, Sentman CL:
Inhibitory receptors alter natural killer cell interactions with target cells yet allow
simultaneous killing of susceptible targets. J Exp Med 190:1005±1012, 1999
Faergemann J: Pityrosporum species as a cause of allergy and infection. Allergy 54:413±
419, 1999
Ferlazzo G, Semino C, Melioli G: HLA class I molecule expression is up-regulated
during maturation of dendritic cells, protecting them from natural killer cell-
mediated lysis. Immunol Lett 76:37±41, 2001
Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, Munz C: Human
dendritic cells activate resting natural killer (NK) cells and are recognized via
the NKp30 receptor by activated NK cells. J Exp Med 195:343±351, 2002
Fernandez NC, Lozier A, Flament C, et al: Dendritic cells directly trigger NK cell
functions: cross-talk relevant in innate anti-tumor immune responses in vivo.
Nat Med 5:405±411, 1999
Geldhof AB, Moser M, Lespagnard L, Thielemans K, De Baetselier P: Interleukin-
12-activated natural killer cells recognize B7 costimulatory molecules on tumor
cells and autologous dendritic cells. Blood 91:196±206, 1998
Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G:
Reciprocal activating interaction between natural killer cells and dendritic cells.
J Exp Med 195:327±333, 2002
Goodier MR, Londei M: Lipopolysaccharide stimulates the proliferation of human
CD56+CD3± NK cells: a regulatory role of monocytes and IL-10. J Immunol
165:139±147, 2000
Granucci F, Vizzardelli C, Pavelka N, et al: Inducible IL-2 production by dendritic
cells revealed by global gene expression analysis. Nat Immunol 2:882±888, 2001
Grufman P, KaÈrre K: Innate and adaptive immunity to tumors: IL-12 is required for
optimal responses. Eur J Immunol 30:1088±1093, 2000
Hashiro M, Okumura M: The relationship between the psychological and
immunological state in patients with atopic dermatitis. J Dermatol Sci 16:231±
235, 1998
ISAAC: Worldwide variation in prevalence of symptoms of asthma, allergic
rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of
Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet
351:1225±1232, 1998
Johansson C, Eshaghi H, Tengvall Linder M, Jacobson E, Scheynius A: Positive
atopy patch test reaction to Malassezia furfur in atopic dermatitis correlates with
a Th2-like PBMC response. J Invest Dermatol 118:1044±1051, 2002
Johansson SGO, Hourihane JO, Bousquet J, et al: A revised nomenclature for allergy.
An EAACI position statement from the EAACI nomenclature task force.
Allergy 56:813±824, 2001
Johnson GD, Davidson RS, McNamee KC, Russell G, Goodwin D, Holborow EJ:
Fading of immuno¯uorescence during microscopy: a study of the phenomenon
and its remedy. J Immunol Meth 55:231±242, 1982
Kaburagi Y, Shimada Y, Nagaoka T, Hasegawa M, Takehara K, Sato S: Enhanced
production of CC-chemokines (RANTES, MCP-1, MIP-1alpha, MIP- 1beta,
and eotaxin) in patients with atopic dermatitis. Arch Dermatol Res 293:350±355,
2001
Korsgren M, Persson CG, Sundler F, et al: Natural killer cells determine development
of allergen-induced eosinophilic airway in¯ammation in mice. J Exp Med
189:553±562, 1999
Lesko MJ, Lever RS, Mackie RM, Parrott DM: The effect of topical steroid
application on natural killer cell activity. Clin Exp Allergy 19:633±636, 1989
Leung DY: Atopic dermatitis: new insights and opportunities for therapeutic
intervention. J Allergy Clin Immunol 105:860±876, 2000
Mayser P, Gross A: IgE antibodies to Malassezia furfur, M. sympodialis and Pityrosporum
orbiculare in patients with atopic dermatitis, seborrheic eczema or pityriasis
versicolor, and identi®cation of respective allergens. Acta Derm Venereol
80:357±361, 2000
Minter RM, Ferry MA, Rectenwald JE, et al: Extended lung expression and
increased tissue localization of viral IL-10 with adenoviral gene therapy. Proc
Natl Acad Sci USA 98:277±282, 2001
Moretta A, Bottino C, Vitale M, et al: Activating receptors and coreceptors involved
in human natural killer cell-mediated cytolysis. Annu Rev Immunol 19:197±223,
2001
Nakamura S, Suchi T, Koshikawa T, et al: Clinicopathologic study of CD56
(NCAM) -positive angiocentric lymphoma occurring in sites other than the
upper and lower respiratory tract. Am J Surg Pathol 19:284±296, 1995
Piccioli D, Sbrana S, Melandri E, Valiante NM: Contact-dependent stimulation and
inhibition of dendritic cells by natural killer cells. J Exp Med 195:335±341, 2002
Romani N, Gruner S, Brang D, et al: Proliferating dendritic cell progenitors in
human blood. J Exp Med 180:83±93, 1994
Romani N, Reider D, Heuer M, et al: Generation of mature dendritic cells from
human blood. An improved method with special regard to clinical applicability.
J Immunol Meth 196:137±151, 1996
Sallusto F, Lanzavecchia A: Ef®cient presentation of soluble antigen by cultured
human dendritic cells is maintained by granulocyte/macrophage colony-
stimulating factor plus interleukin 4 and downregulated by tumor necrosis
factor alpha. J Exp Med 179:1109±1118, 1994
Scheynius A, Johansson C, Buentke E, Zargari A, Tengvall Linder M: Atopic
eczema/dermatitis syndrome and Malassezia. Int Arch Dermatol 127:161±169,
2002
Spaggiari GM, Carosio R, Pende D, et al: NK cell-mediated lysis of autologous
antigen-presenting cells is triggered by the engagement of the
phosphatidylinositol 3-kinase upon ligation of the natural cytotoxicity
receptors NKp30 and NKp46. Eur J Immunol 31:1656±1665, 2001
StrannegaÊrd IL, StrannegaÊrd OÈ : Natural killer cells and interferon production in
atopic dermatitis. Acta Dermato-Venereologica Suppl 92:48, 1980
Tengvall Linder M, Johansson C, Scheynius A, Wahlgren C: Positive atopy patch test
856 BUENTKE ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
reactions to Pityrosporum orbiculare in atopic dermatitis patients. Clin Exp Allergy
30:122±131, 2000
Vulcano M, Albanesi C, Stoppacciaro A, et al: Dendritic cells as a major source of
macrophage-derived chemokine/CCL22 in vitro and in vivo. Eur J Immunol
31:812±822, 2001
Wehrmann W, Reinhold U, Kukel S, Franke N, Uerlich M, Kreysel HW: Selective
alterations in natural killer cell subsets in patients with atopic dermatitis. Int Arch
Allergy Appl Immunol 92:318±322, 1990
Werfel T, Kapp A: Environmental and other major provocation factors in atopic
dermatitis. Allergy 53:731±739, 1998
Wilson JL, Hef¯er LC, Charo J, Scheynius A, Bejarano MT, Ljunggren HG:
Targeting of human dendritic cells by autologous NK cells. J Immunol
163:6365±6370, 1999
Zachary CB, Allen MH, MacDonald DM: In situ quanti®cation of T-lymphocyte
subsets and Langerhans cells in the in¯ammatory in®ltrate of atopic eczema. Br J
Dermatol 112:149±156, 1985
Zhou LJ, Tedder TF: CD14+ blood monocytes can differentiate into functionally
mature CD83+ dendritic cells. Proc Natl Acad Sci USA 93:2588±2592, 1996
VOL. 119, NO. 4 OCTOBER 2002 DC AND NK CELL INTERACTION IN AD PATIENTS 857
